Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence
Introduction Obesity affects over 650 million adults worldwide and is a major risk factor for cardiovascular diseases and type 2 diabetes. Among those affected are patients treated with antipsychotics, such as clozapine and olanzapine, which often lead to significant weight gain, increasing the ris...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Kazimierz Wielki University
2024-12-01
|
| Серія: | Journal of Education, Health and Sport |
| Предмети: | |
| Онлайн доступ: | https://apcz.umk.pl/JEHS/article/view/56672 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|